A Specific CRH antagonist attenuates ACTH-stimulated cortisol secretion in ovine adrenocortical cells

Reproductive Sciences

Volumn 17, Issue 5, 2010, Pages 477-486

  Valego, Nancy K ^a   Rose, James C ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Cell proliferation.; CRH receptor antagonist; Cultured ovine adrenocortical cells; Fetal adrenal

Indexed keywords

ANTALARMIN; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CYCLIC AMP; FORSKOLIN; HYDROCORTISONE;

ADRENAL CORTEX CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CORTICOSTEROID RELEASE; FEMALE; HORMONE BINDING; HORMONE RESPONSE; HYDROCORTISONE RELEASE; HYPOTHESIS; NONHUMAN; PRIORITY JOURNAL; SHEEP;

ADRENAL CORTEX; ADRENOCORTICOTROPIC HORMONE; ANIMALS; CELLS, CULTURED; CORTICOTROPIN-RELEASING HORMONE; FEMALE; HYDROCORTISONE; PEPTIDE FRAGMENTS; PREGNANCY; PYRIMIDINES; PYRROLES; SHEEP;

EID: 77950560186     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719110361959     Document Type: Article

References (63)

1. Rainey WE, Saner K., Schimmer BP Adrenocortical cell lines. Mol Cell Endocrinol. 2004 ; 228 (1-2). 23-38. (Pubitemid 39482517)
2. Whittle WL, Patel FA, Alfaidy N., et al. Glucocorticoid regulation of human and ovine parturition: the relationship between fetal hypothalamic- pituitary-adrenal axis activation and intrauterine prostaglandin production. Biol Reprod. 2001 ; 64 (4). 1019-1032. (Pubitemid 32239171)
3. Challis JR, Brooks AN Maturation and activation of hypothalamic-pituitary adrenal function in fetal sheep. Endocr Rev. 1989 ; 10 (2). 182-204.
4. Rainey WE, Oka K., Magness RR, Mason JI Ovine fetal adrenal synthesis of cortisol: regulation by adrenocorticotropin, angiotensin II and transforming growth factor-beta. Endocrinology. 1991 ; 129 (4). 1784-1790.
5. Saez JM, Durand P., Cathiard AM Ontogeny of the ACTH receptor, adenylate cyclase and steroidogenesis in adrenal. Mol Cell Endocrinol. 1984 ; 38 (2-3). 93-102. (Pubitemid 15191238)
6. Challis JRG, Matthews SG, Gibb W., Lye SJ Endocrine and paracrine regulation of birth at term and preterm. Endocr Rev. 2000 ; 21 (5). 514-550.
7. Dermitzaki E., Tsatsanis C., Minas V., et al. Corticotropin-releasing factor (CRF) and the urocortins differentially regulate catecholamine secretion in human and rat adrenals, in a CRF receptor type-specific manner. Endocrinology. 2007 ; 148 (4). 1524-1538.
8. Chatzaki E., Margioris AN, Gravanis A. Expression and regulation of corticotropin-releasing hormone binding protein (CRH-BP) in rat adrenals. J Neurochem. 2002 ; 80 (1). 81-90. (Pubitemid 34614580)
9. Muller MB, Preil J., Renner U., et al. Expression of CRHR1 and CRHR2 in mouse pituitary and adrenal gland: implications for HPA system regulation. Endocrinology. 2001 ; 142 (9). 4150-4153. (Pubitemid 32802688)
10. Bruhn TO, Engeland WC, Anthony EL, Gann DS, Jackson IM Corticotropin-releasing factor in the adrenal medulla. Ann N Y Acad Sci. 1987 ; 512: 115-128.
11. Wietfeld D., Heinrich N., Furkert J., et al. Regulation of the coupling to different G proteins of rat corticotropin-releasing factor receptor type 1 in human embryonic kidney 293 cells. J Biol Chem. 2004 ; 279 (37). 38386-38394. (Pubitemid 39295988)
12. Pomerantz JE, Li C., Nathanielsz PW, McDonald TJ Corticotropin-releasing hormone-like axons in the adrenal glands of fetal and postnatal sheep. J Auton Nerv Syst. 1996 ; 59 (1-2). 87-90. (Pubitemid 26227679)
13. Minamino N., Uehara A., Arimura A. Biological and immunological characterization of corticotropin-releasing activity in the bovine adrenal medulla. Peptides. 1988 ; 9 (1). 37-45. (Pubitemid 18070128)
14. Willenberg HS, Bornstein SR, Hiroi N., et al. Effects of a novel corticotropin-releasing-hormone receptor type I antagonist on human adrenal function. Mol Psychiatry. 2000 ; 5 (2). 137-141. (Pubitemid 30229427)
15. Sirianni R., Mayhew BA, Carr BR, Parker CR, Jr, Rainey WE Corticotropin-releasing hormone (CRH) and urocortin act through type 1 CRH receptors to stimulate dehydroepiandrosterone sulfate production in human fetal adrenal cells. J Clin Endocrinol Metab. 2005 ; 90 (9). 5393-5400. (Pubitemid 41262307)
16. Willenberg HS, Haase M., Papewalis C., Schott M., Scherbaum WA, Bornstein SR Corticotropin-releasing hormone receptor expression on normal and tumorous human adrenocortical cells. Neuroendocrinology. 2005 ; 82 (5-6). 274-281. (Pubitemid 43800874)
17. Karteris E., Randeva HS, Grammatopoulos DK, Jaffe RB, Hillhouse EW Expression and coupling characteristics of the CRH and orexin type 2 receptors in human fetal adrenals. J Clin Endocrinol Metab. 2001 ; 86 (9). 4512-4519. (Pubitemid 32848582)
18. Tsatsanis C., Dermitzaki E., Venihaki M., et al. The corticotropin- releasing factor (CRF) family of peptides as local modulators of adrenal function. Cell Mol Life Sci. 2007 ; 64 (13). 1638-1655. (Pubitemid 47036937)
19. Mesiano S., Jaffe RB Developmental and functional biology of the primate fetal adrenal cortex. Endocr Rev. 1997 ; 18 (3). 378-403. (Pubitemid 27246882)
20. Sirianni R., Rehman KS, Carr BR, Parker CR, Jr, Rainey WE Corticotropin-releasing hormone directly stimulates cortisol and the cortisol biosynthetic pathway in human fetal adrenal cells. J Clin Endocrinol Metab. 2005 ; 90 (1). 279-285. (Pubitemid 40116669)
21. Chan EC, Falconer J., Madsen G., et al. A corticotropin-releasing hormone type I receptor antagonist delays parturition in sheep. Endocrinology. 1998 ; 139 (7). 3357-3360. (Pubitemid 28512369)
22. Young IR, Chan EC, Smith R., Chrousos GP, Veldhuis JD, Canny BJ Effect of antalarmin, a novel corticotropin-releasing hormone antagonist, on the dynamic function of the preterm ovine fetal hypothalamo-pituitary-adrenal axis. Neuroendocrinology. 2002 ; 76 (1). 47-54. (Pubitemid 34827799)
23. Wong ML, Webster EL, Spokes H., et al. Chronic administration of the non-peptide CRH type 1 receptor antagonist antalarmin does not blunt hypothalamic-pituitary-adrenal axis responses to acute immobilization stress. Life Sci. 1999 ; 65 4 ): L53 - L58. (Pubitemid 29325290)
24. Rainey WE, Viard I., Saez JM Transforming growth factor beta treatment decreases ACTH receptors on ovine adrenocortical cells. J Biol Chem. 1989 ; 264 (36). 21474-21477. (Pubitemid 20028704)
25. Beshay VE, Carr BR, Rainey WE The human fetal adrenal gland, corticotropin-releasing hormone, and parturition. Semin Reprod Med. 2007 ; 25 (1). 14-20.
26. Wintour ME Developmental aspects of the hypothalamic-pituitary-adrenal axis. J Dev Physiol. 1984 ; 6 (3). 291-299.
27. Boshier DP, Holloway H. Morphometric analyses of adrenal gland growth in fetal and neonatal sheep. I. The adrenal cortex. J Anat. 1989 ; 167: 1-14. (Pubitemid 20036017)
28. Webb PD Development of the adrenal cortex in the fetal sheep: an ultrastructural study. J Dev Physiol. 1980 ; 2 (3). 161-181. (Pubitemid 11101471)
29. Rehman KS, Sirianni R., Parker CR, Jr, Rainey WE, Carr BR The regulation of adrenocorticotrophic hormone receptor by corticotropin-releasing hormone in human fetal adrenal definitive/transitional zone cells. Reprod Sci. 2007 ; 14 (6). 578-587. (Pubitemid 351168791)
30. Rundle SE, Canny BJ, Robinson PM, Funder JW Innervation of the sheep adrenal cortex: an immunohistochemical study with rat corticotrophin-releasing factor antiserum. Neuroendocrinology. 1988 ; 48 (1). 8-15.
31. Berger H., Heinrich N., Wietfeld D., Bienert M., Beyermann M. Evidence that corticotropin-releasing factor receptor type 1 couples to Gs- and Gi-proteins through different conformations of its J-domain. Br J Pharmacol. 2006 ; 149 (7). 942-947. (Pubitemid 44851718)
32. Hoare SR, Sullivan SK, Ling N., Crowe PD, Grigoriadis DE Mechanism of corticotropin-releasing factor type I receptor regulation by nonpeptide antagonists. Mol Pharmacol. 2003 ; 63 (3). 751-765. (Pubitemid 36297349)
33. Graziani G., Tentori L., Muzi A., et al. Evidence that corticotropin-releasing hormone inhibits cell growth of human breast cancer cells via the activation of CRH-R1 receptor subtype. Mol Cell Endocrinol. 2007 29; 264 (1-2). 44-49. (Pubitemid 46097300)
34. Webster EL, Lewis DB, Torpy DJ, Zachman EK, Rice KC, Chrousos GP In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin- releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation. Endocrinology. 1996 ; 137 (12). 5747-5750.
35. Schulz DW, Mansbach RS, Sprouse J., et al. CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors. Proc Natl Acad Sci U S A. 1996 ; 93 (19). 10477-10482. (Pubitemid 26314648)
36. Ayala AR, Pushkas J., Higley JD, et al. Behavioral, adrenal, and sympathetic responses to long-term administration of an oral corticotropin-releasing hormone receptor antagonist in a primate stress paradigm. J Clin Endocrinol Metab. 2004 ; 89 (11). 5729-5737. (Pubitemid 39518466)
37. Bornstein SR, Webster EL, Torpy DJ, et al. Chronic effects of a nonpeptide corticotropin-releasing hormone type I receptor antagonist on pituitary-adrenal function, body weight, and metabolic regulation. Endocrinology. 1998 ; 139 (4). 1546-1555.
38. Broadbear JH, Winger G., Rivier JE, Rice KC, Woods JH Corticotropin-releasing hormone antagonists, astressin B and antalarmin: differing profiles of activity in rhesus monkeys. Neuropsychopharmacology. 2004 ; 29 (6). 1112-1121. (Pubitemid 38670049)
39. Seamon KB, Padgett W., Daly JW Forskolin: unique diterpene activator of adenylate cyclase in membranes and in intact cells. Proc Natl Acad Sci U S A. 1981 ; 78 (6). 3363-3367. (Pubitemid 11059290)
40. de Souza NJ, Dohadwalla AN, Reden J. Forskolin: a labdane diterpenoid with antihypertensive, positive inotropic, platelet aggregation inhibitory, and adenylate cyclase activating properties. Med Res Rev. 1983 ; 3 (2). 201-219. (Pubitemid 13059326)
41. Ito H., Wang J., Strandhoy JW, Rose JC Importance of the renal nerves for basal and stimulated renin mRNA levels in fetal and adult ovine kidneys. J Soc Gynecol Investig. 2001 ; 8 (6). 327-333. (Pubitemid 34031761)
42. Lazareno S., Marriott DB, Nahorski SR Differential effects of selective and non-selective neuroleptics on intracellular and extracellular cyclic AMP accumulation in rat striatal slices. Brain Res. 1985 ; 361 (1-2). 91-98. (Pubitemid 16185389)
43. Simpson ER, Waterman MR Regulation of the synthesis of steroidogenic enzymes in adrenal cortical cells by ACTH. Annu Rev Physiol. 1988 ; 50: 427-440.
44. Rivier J., Rivier C., Vale W. Synthetic competitive antagonists of corticotropin-releasing factor: effect on ACTH secretion in the rat. Science. 1984 ; 224 (4651). 889-891. (Pubitemid 14102465)
45. Rivier J., Gulyas J., Kirby D., et al. Potent and long-acting corticotropin releasing factor (CRF) receptor 2 selective peptide competitive antagonists. J Med Chem. 2002 ; 45 (21). 4737-4747.
46. Ehrhart-Bornstein M., Hinson JP, Bornstein SR, Scherbaum WA, Vinson GP Intraadrenal interactions in the regulation of adrenocortical steroidogenesis. Endocr Rev. 1998 ; 19 (2). 101-143. (Pubitemid 29114288)
47. Mesiano S., Jaffe RB Role of growth factors in the developmental regulation of the human fetal adrenal cortex. Steroids. 1997 ; 62 (1). 62-72. (Pubitemid 27066987)
48. Coulter CL, Ross JT, Owens JA, Bennett HP, McMillen IC Role of pituitary POMC-peptides and insulin-like growth factor II in the developmental biology of the adrenal gland. Arch Physiol Biochem. 2002 ; 110 (1-2). 99-105.
49. Simonian MH, Gill GN Regulation of the fetal human adrenal cortex: effects of adrenocorticotropin on growth and function of monolayer cultures of fetal and definitive zone cells. Endocrinology. 1981 ; 108 (5). 1769-1779.
50. Ramachandran J., Suyama AT Inhibition of replication of normal adrenocortical cells in culture by adrenocorticotropin. Proc Natl Acad Sci U S A. 1975 ; 72 (1). 113-117.
51. Di Blasio AM, Fujii DK, Yamamoto M., Martin MC, Jaffe RB Maintenance of cell proliferation and steroidogenesis in cultured human fetal adrenal cells chronically exposed to adrenocorticotropic hormone: rationalization of in vitro and in vivo findings. Biol Reprod. 1990 ; 42 (4). 683-691. (Pubitemid 20168890)
52. Hornsby PJ, Gill GN Hormonal control of adrenocortical cell proliferation. Desensitization to ACTH and interaction between ACTH and fibroblast growth factor in bovine adrenocortical cell cultures. J Clin Invest. 1977 ; 60 (2). 342-352.
53. Arola J., Heikkila P., Voutilainen R., Kahri AI Role of adenylate cyclase-cyclic AMP-dependent signal transduction in the ACTH-induced biphasic growth effect of rat adrenocortical cells in primary culture. J Endocrinol. 1993 ; 139 (3). 451-461.
54. Thomas M., Keramidas M., Monchaux E., Feige JJ Dual hormonal regulation of endocrine tissue mass and vasculature by adrenocorticotropin in the adrenal cortex. Endocrinology. 2004 ; 145 (9). 4320-4329.
55. Rainey WE, Naville D., Cline N., Mason JI Prostaglandin E2 is a positive regulator of adrenocorticotropin receptors, 3 beta-hydroxysteroid dehydrogenase, and 17 alpha-hydroxylase expression in bovine adrenocortical cells. Endocrinology. 1991 ; 129 (3). 1333-1339.
56. Penhoat A., Leduque P., Jaillard C., Chatelain PG, Dubois PM, Saez JM ACTH and angiotensin II regulation of insulin-like growth factor-I and its binding proteins in cultured bovine adrenal cells. J Mol Endocrinol. 1991 ; 7 (3). 223-232.
57. Schweigerer L., Neufeld G., Friedman J., Abraham JA, Fiddes JC, Gospodarowicz D. Basic fibroblast growth factor: production and growth stimulation in cultured adrenal cortex cells. Endocrinology. 1987 ; 120 (2). 796-800. (Pubitemid 17020440)
58. Baccaro RB, Mendonca PO, Torres TE, Lotfi CF Immunohistochemical Jun/Fos protein localization and DNA synthesis in rat adrenal cortex after treatment with ACTH or FGF2. Cell Tissue Res. 2007 ; 328 (1). 7-18.
59. Horn TL, Harder JB, Johnson WD, et al. Integration of in vivo and in vitro approaches to characterize the toxicity of antalarmin, a corticotropin-releasing hormone receptor antagonist. Toxicology. 2008 ; 248 (1). 8-17.
60. Contoreggi C., Rice KC, Chrousos G. Nonpeptide corticotropin-releasing hormone receptor type 1 antagonists and their applications in psychosomatic disorders. Neuroendocrinology. 2004 ; 80 (2). 111-123.
61. Elenkov IJ, Webster EL, Torpy DJ, Chrousos GP Stress, corticotropin-releasing hormone, glucocorticoids, and the immune/inflammatory response: acute and chronic effects. Ann N Y Acad Sci. 1999 ; 876: 1-11.
62. Marinelli PW, Funk D., Juzytsch W., et al. The CRF1 receptor antagonist antalarmin attenuates yohimbine-induced increases in operant alcohol self-administration and reinstatement of alcohol seeking in rats. Psychopharmacology (Berl). 2007 ; 195 (3). 345-355.
63. Biller BM, Grossman AB, Stewart PM, et al. Treatment of ACTH-dependent Cushingĝs syndrome: a consensus statement. J Clin Endocrinol Metab. 2008 ; 93 (7). 2454-2462.